Ratings
0
Nobody has rated this yet. Be the first!
Works
13
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
Mutation screening of the RNF8, UBC13 and MMS2 genes in Northern Finnish breast cancer families
Inactivation of Palb2 gene leads to mesoderm differentiation defect and early embryonic lethality in mice
A recurrent mutation in PALB2 in Finnish cancer families
Recurrent CYP2C19 deletion allele is associated with triple-negative breast cancer
Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility
Screening for large genomic rearrangements of the BRIP1 and CHK1 genes in Finnish breast cancer families
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
